Agile Therapeutics to Present at Upcoming March Investor Conferences
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will present at two investor conferences in March.
- H.C. Wainwright Global Life Sciences Conference
- On demand beginning Tuesday, March 9, 2021 at 7:00 a.m. ET
- Oppenheimer 31st Annual Virtual Healthcare Conference
- Wednesday, March 17, 2021 at 8:40 a.m. ET
Presentations from each conference will be webcast on the Investors section of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. Each archived webcast will be available for 30 days.
About Agile Therapeutics, Inc.Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Contact: Matt RileyHead of Investor Relations & Corporate Communicationsmriley@agiletherapeutics.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021
- Kibali Goldmines Rejects SOKIMO Claim
- GLOBAL TECH INDUSTRIES GROUP, INC. CLARIFIES WARRANT DISTRIBUTION